Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study.

[1]  J. Dunn,et al.  Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial , 2020, Oral Oncology.

[2]  S. Bhide,et al.  Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer. , 2020 .

[3]  N. Iles,et al.  TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  V. Grégoire,et al.  Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the “Best of” Trial , 2019, Front. Oncol..

[5]  K. Fung,et al.  Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. , 2019, The Lancet. Oncology.

[6]  D. Palma,et al.  Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers? , 2019, Advances in radiation oncology.

[7]  C. R. Leemans,et al.  Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial , 2019, The Lancet.

[8]  S. Giordano,et al.  Two‐year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER‐Medicare analysis , 2018, Head & neck.

[9]  W. Tomé,et al.  Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports. , 2018, International journal of radiation oncology, biology, physics.

[10]  A. Garden,et al.  Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. , 2017, International journal of radiation oncology, biology, physics.

[11]  S. Bhide,et al.  DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer , 2016, BMC Cancer.

[12]  Steven J Frank,et al.  Intensity-Modulated Proton Therapy ( IMPT ) versus Intensity-Modulated Photon Radiotherapy ( IMRT ) for Oropharyngeal Cancer : First Comparative Results of Patient-Reported Outcomes , 2016 .

[13]  Steven J Frank,et al.  Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  R. Mohan,et al.  Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. , 2016, International journal of radiation oncology, biology, physics.

[15]  J. Lewin,et al.  What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients? , 2016, The Laryngoscope.

[16]  Mark W. McDonald,et al.  Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy , 2016, Radiation Oncology.

[17]  Jayashree Kalpathy-Cramer,et al.  Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  C. Hurt,et al.  PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer , 2015, BMC Cancer.

[19]  P. Carding,et al.  Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia? , 2014, Oral oncology.

[20]  J. Thariat,et al.  [Microscopic extensions of head and neck squamous cell carcinomas: impact for clinical target volume definition]. , 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[21]  A. Hartley,et al.  Four Week Hypofractionated Accelerated Intensity Modulated Radiotherapy and Synchronous Carboplatin or Cetuximab in Biologically Staged Oropharyngeal Carcinoma , 2014 .

[22]  D. Spratt,et al.  Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  Quynh-Thu Le,et al.  Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  T. Roques,et al.  Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[25]  Johannes A Langendijk,et al.  Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  Dan Wang,et al.  Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers. , 2012, International journal of radiation oncology, biology, physics.

[27]  A. Hartley,et al.  Variation in volume definition between UK head and neck oncologists treating oropharyngeal carcinoma. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  P. Carding,et al.  Dysphagia after Nonsurgical Head and Neck Cancer Treatment , 2011, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[29]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[30]  R. Morton,et al.  Elective gastrostomy, nutritional status and quality of life in advanced head and neck cancer patients receiving chemoradiotherapy , 2009, ANZ journal of surgery.

[31]  E. Vokes,et al.  Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. , 2008, Archives of otolaryngology--head & neck surgery.

[32]  N. Aaronson,et al.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  P. Levendag,et al.  Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  R. Frankowski,et al.  The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. , 2001, Archives of otolaryngology--head & neck surgery.

[35]  T. Mekhail,et al.  Enteral nutrition during the treatment of head and neck carcinoma , 2001, Cancer.

[36]  Facs Po Wing Yuen Frcs,et al.  Clinicopathological Analysis of Local Spread of Carcinoma of the Tongue 11The study was supported by a research grant from the University of Hong Kong, grant number 337/048/0014 and 335/048/0081. , 1998 .